Research Article

The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients

Table 6

Outcomes for patients with CAEs in patients by serum magnesium target group.

Patients with CAEs—with serum ()Patients with CAE—with serum () value

Early outcomes
 Nurse GCS, median (IQR)13 (10-15)15 (12-15)0.04
 Nurse LAMS, median (IQR)5 (3-5)5 (3-5)0.68
 Nurse NIHSS, mean (SD)17.1 (10.4)14.3 (8.6)0.08
90-day outcomes
 mRS 90 d 0-1, (%)3 (6.4)20 (18.0)0.08
 mRS 90 d 0-2, (%)30 (27.0)9 (19.1)0.32
 mRS 90 d, mean (SD)4.4 (1.8)4.0 (2.1)0.26
 Mortality 90 d, (%)18 (38.3)41 (36.6)0.85